Uterine myomatosis

Uterine myomatosis is the appearance of fibroids or fibroids in a woman's uterus. These are the most common pelvic tumour, as approximately 20% of women of reproductive age suffer from them.

These are benign tumours that are classified according to their location, which can be:
- Intramural
- Submucosal
- Subserosal


Although the specific cause of uterine fibroids is not known, their occurrence is thought to be related to a genetic predisposition. Their growth is also associated with the hormonal activity of the ovaries, in particular the production of oestrogen and progesterone.

Uterine fibroids appear during a woman's reproductive years, grow during pregnancy (when hormone levels are high) and disappear after menopause, when hormone levels are lower.


Approximately 25% of uterine fibroids are asymptomatic. However, they can also manifest themselves through:

Feeling of pressure in the lower abdomen
Heavy menstrual bleeding
Longer than normal menstrual periods
Pelvic cramps or painful menstrual periods
Bleeding not related to menstruation
Difficulty or pain when urinating
Recurrent miscarriages
It is important to note that the symptoms of uterine myomatosis depend on the size, location and number of fibroids present.


Uterine fibroids are often found accidentally during a routine pelvic examination. Irregularities in the shape of the uterus may be felt, suggesting the presence of fibroids.

A specialist may order an ultrasound to obtain an image of the uterus to confirm the diagnosis and to map and measure the fibroids.

Can I have a baby if I have uterine myomatosis?

Treatment may include:

- Oral contraceptives
- Brief preoperative gonadotropin-releasing hormone therapy to shrink fibroids
- Progestogen therapy
- More definitive surgical procedures
(e.g. hysterectomy, myomectomy).

Come to our reproduction specialists and find the best alternative to have a baby at home. 
Contact us

Cofepris Permit: 133300201A1156 
Dr. Felipe Camargo Professional ID SEP: 4452501  
All rights reserved 2021. Ingenes Institute, Fertility & Genetics